Lakefront Biotherapeutics
LKFT
#4601
Rank
A$3.29 B
Marketcap
A$50.32
Share price
-0.24%
Change (1 day)
N/A
Change (1 year)

EPS for Lakefront Biotherapeutics (LKFT)

EPS in 2026 (TTM): A-$0.84

According to Lakefront Biotherapeutics's latest financial reports the company's current EPS (TTM) is A-$0.62. In 2025 the company made an earnings per share (EPS) of A$8.64 an increase over its 2024 EPS that were of A$1.76.

EPS history for Lakefront Biotherapeutics from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.84-109.71%
2025A$8.64390.86%
2024A$1.76-67.16%
2023A$5.36-199.64%
2022A-$5.3899.03%
2021A-$2.70-68.98%
2020A-$8.72-298.06%
2019A$4.40-554.64%
2018A-$0.97-77.18%
2017A-$4.24-326.21%
2016A$1.88-134.19%
2015A-$5.48-371.34%
2014A$2.02-445.98%
2013A-$0.5832.88%
2012A-$0.44-82.07%
2011A-$2.45-817.9%
2010A$0.3412.73%
2009A$0.30-120.79%
2008A-$1.46-37.67%
2007A-$2.3439.64%
2006A-$1.6728.17%
2005A-$1.316.25%
2004A-$1.23